Are peptides safe and legal? What the FDA ruling means in the US and UK

Updated 10 August 2026. Regulatory status current as of this date. Most approved peptide medicines are legal when prescribed appropriately. But wellness and lifestyle peptides such as BPC-157, TB-500 and MOTS-c remain unapproved and unproven; the FDA’s July 2026 advisory vote did not make them approved or immediately legal to compound. UK rules depend partly…

ByJon LipseyAugust 10, 20260Comments

TECH

The GLP-1 boom has a retention problem. Withings has a fix

Give a patient a GLP-1 prescription and send them home, and there is a decent chance the drug outlives their commitment to it. Six-month retention runs at around 45 per cent, by the estimate of a company sitting on data from more than 600,000 GLP-1 patients. Wrap the same drug in a coaching service and…

ByJon LipseyJuly 3, 20260Comments

HEALTH Obesity crisis

Eli Lilly advances retatrutide to Phase 3 to expand next-generation multi-hormone obesity therapeutics

Eli Lilly is progressing its experimental obesity and type 2 diabetes drug retatrutide into Phase 3 trials, following late-stage data showing significant weight loss and metabolic improvements. Retatrutide belongs to a new class of drugs known as triple agonists, targeting three key metabolic pathways simultaneously. In earlier trials, the drug demonstrated weight loss outcomes exceeding…

ByJon LipseyMarch 26, 20260Comments

HEALTH Obesity crisis

Metabolic ill health will cost the global economy trillions

McKinsey Health Institute recently released a 59-page report on global metabolic health — and the numbers are impossible to ignore. Around 900 million adults worldwide are obese, and more than 20 chronic diseases, from diabetes to dementia, are directly linked to obesity. The economic impact is equally severe: $2.76 trillion in GDP could be wiped…

ByJon LipseyFebruary 1, 20260Comments

Donut obesity sugar insulin diabetes healthcare ozempic HAES

HEALTH Opinion

Who’s really to blame for the global obesity epidemic?

Professor Jane Ogden Jane Ogden is a professor of health psychology at the University of Surrey. She has been researching eating behaviour, weight management and women’s health for more than 30 years, and has written several informative books on the subject, including “The Psychology of Eating” and “The Psychology of Dieting”. We’re living through a…

ByMark BaileyJuly 31, 20240Comments

Ozempic weight loss drugs GLP-1 diabetes healthcare

HEALTH Obesity crisis

Dr Stephen Lawrence: The truth about Ozempic and weight-loss drugs

Dr Stephen Lawrence Dr Stephen Lawrence is a GP and an Associate Clinical Professor at the University of Warwick. He is director of the largest Masters diabetes course in the world and has served as Clinical Diabetes Lead for the Royal College of General Practitioners. A new generation of weight-loss drugs, like Wegovy from Danish…

ByMark BaileyJuly 9, 20240Comments

Newsletter

Sign Up to Our Newsletter